title: Ventral fusion versus dorsal fusion: determining the optimal treatment for cervical spondylotic myelopathy.
abstract: Cervical spondylotic myelopathy (CSM) often can be surgically treated by either ventral or dorsal decompression and fusion. However, there is a lack of high-level evidence on the relative advantages and disadvantages for these treatments of CSM. The authors' goal was to provide a comprehensive review of the relative benefits of ventral versus dorsal fusion in terms of quality of life (QOL) outcomes, complications, and costs. They reviewed 7 studies on CSM published between 2003 and 2013 and summarized the findings for each category. Both procedures have been shown to lead to statistically significant improvement in clinical outcomes for patients. Ventral fusion surgery has been shown to yield better QOL outcomes than dorsal fusion surgery. Complication rates for ventral fusion surgery range from 11% to 13.6%, whereas those for dorsal fusion surgery range from 16.4% to 19%. Larger randomized controlled trials are needed, with particular emphasis on QOL and minimum clinically important differences.
authors.affiliation: Cleveland Clinic Center for Spine Health, Cleveland Clinic, Cleveland, Ohio 44195, USA.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Alvin
authors.forename: Daniel
authors.initials: D
authors.lastname: Lubelski
authors.forename: Edward C
authors.initials: EC
authors.lastname: Benzel
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Mroz
mesh_terms: D002574:Cervical Vertebrae / Q000473:pathology / Q000601:surgery*; D006801:Humans; D013118:Spinal Cord Diseases / Q000175:diagnosis / Q000601:surgery*; D013123:Spinal Fusion / Q000379:methods*; D055009:Spondylosis / Q000175:diagnosis / Q000601:surgery*; D016896:Treatment Outcome